List of Tables
Table 1. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Age-Related Macular Degeneration (AMD) AI Screening System Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Age-Related Macular Degeneration (AMD) AI Screening System Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Age-Related Macular Degeneration (AMD) AI Screening System Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Age-Related Macular Degeneration (AMD) AI Screening System Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Age-Related Macular Degeneration (AMD) AI Screening System Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Age-Related Macular Degeneration (AMD) AI Screening System by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Age-Related Macular Degeneration (AMD) AI Screening System as of 2024)
Table 11. Global Age-Related Macular Degeneration (AMD) AI Screening System Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Age-Related Macular Degeneration (AMD) AI Screening System Companies Headquarters
Table 13. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Age-Related Macular Degeneration (AMD) AI Screening System Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Age-Related Macular Degeneration (AMD) AI Screening System Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Age-Related Macular Degeneration (AMD) AI Screening System Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Age-Related Macular Degeneration (AMD) AI Screening System Revenue by Application (2026-2031) & (US$ Million)
Table 21. Age-Related Macular Degeneration (AMD) AI Screening System High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Age-Related Macular Degeneration (AMD) AI Screening System Growth Accelerators and Market Barriers
Table 25. North America Age-Related Macular Degeneration (AMD) AI Screening System Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Age-Related Macular Degeneration (AMD) AI Screening System Growth Accelerators and Market Barriers
Table 27. Europe Age-Related Macular Degeneration (AMD) AI Screening System Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Age-Related Macular Degeneration (AMD) AI Screening System Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Age-Related Macular Degeneration (AMD) AI Screening System Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Age-Related Macular Degeneration (AMD) AI Screening System Investment Opportunities and Key Challenges
Table 31. Central and South America Age-Related Macular Degeneration (AMD) AI Screening System Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Age-Related Macular Degeneration (AMD) AI Screening System Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Age-Related Macular Degeneration (AMD) AI Screening System Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Airdoc Technology Corporation Information
Table 35. Airdoc Technology Description and Major Businesses
Table 36. Airdoc Technology Product Features and Attributes
Table 37. Airdoc Technology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Airdoc Technology Revenue Proportion by Product in 2024
Table 39. Airdoc Technology Revenue Proportion by Application in 2024
Table 40. Airdoc Technology Revenue Proportion by Geographic Area in 2024
Table 41. Airdoc Technology Age-Related Macular Degeneration (AMD) AI Screening System SWOT Analysis
Table 42. Airdoc Technology Recent Developments
Table 43. Digital Diagnostics Corporation Information
Table 44. Digital Diagnostics Description and Major Businesses
Table 45. Digital Diagnostics Product Features and Attributes
Table 46. Digital Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Digital Diagnostics Revenue Proportion by Product in 2024
Table 48. Digital Diagnostics Revenue Proportion by Application in 2024
Table 49. Digital Diagnostics Revenue Proportion by Geographic Area in 2024
Table 50. Digital Diagnostics Age-Related Macular Degeneration (AMD) AI Screening System SWOT Analysis
Table 51. Digital Diagnostics Recent Developments
Table 52. Eyenuk Corporation Information
Table 53. Eyenuk Description and Major Businesses
Table 54. Eyenuk Product Features and Attributes
Table 55. Eyenuk Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Eyenuk Revenue Proportion by Product in 2024
Table 57. Eyenuk Revenue Proportion by Application in 2024
Table 58. Eyenuk Revenue Proportion by Geographic Area in 2024
Table 59. Eyenuk Age-Related Macular Degeneration (AMD) AI Screening System SWOT Analysis
Table 60. Eyenuk Recent Developments
Table 61. RetinaLyze System Corporation Information
Table 62. RetinaLyze System Description and Major Businesses
Table 63. RetinaLyze System Product Features and Attributes
Table 64. RetinaLyze System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. RetinaLyze System Revenue Proportion by Product in 2024
Table 66. RetinaLyze System Revenue Proportion by Application in 2024
Table 67. RetinaLyze System Revenue Proportion by Geographic Area in 2024
Table 68. RetinaLyze System Age-Related Macular Degeneration (AMD) AI Screening System SWOT Analysis
Table 69. RetinaLyze System Recent Developments
Table 70. Optomed Corporation Information
Table 71. Optomed Description and Major Businesses
Table 72. Optomed Product Features and Attributes
Table 73. Optomed Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Optomed Revenue Proportion by Product in 2024
Table 75. Optomed Revenue Proportion by Application in 2024
Table 76. Optomed Revenue Proportion by Geographic Area in 2024
Table 77. Optomed Age-Related Macular Degeneration (AMD) AI Screening System SWOT Analysis
Table 78. Optomed Recent Developments
Table 79. Sibionics Technology Corporation Information
Table 80. Sibionics Technology Description and Major Businesses
Table 81. Sibionics Technology Product Features and Attributes
Table 82. Sibionics Technology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Sibionics Technology Recent Developments
Table 84. Aeye Health Corporation Information
Table 85. Aeye Health Description and Major Businesses
Table 86. Aeye Health Product Features and Attributes
Table 87. Aeye Health Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Aeye Health Recent Developments
Table 89. VUNO Corporation Information
Table 90. VUNO Description and Major Businesses
Table 91. VUNO Product Features and Attributes
Table 92. VUNO Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. VUNO Recent Developments
Table 94. Medimaging Integrated Solution Corporation Information
Table 95. Medimaging Integrated Solution Description and Major Businesses
Table 96. Medimaging Integrated Solution Product Features and Attributes
Table 97. Medimaging Integrated Solution Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Medimaging Integrated Solution Recent Developments
Table 99. EyRIS (SELENA+) Corporation Information
Table 100. EyRIS (SELENA+) Description and Major Businesses
Table 101. EyRIS (SELENA+) Product Features and Attributes
Table 102. EyRIS (SELENA+) Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. EyRIS (SELENA+) Recent Developments
Table 104. Vistel Corporation Information
Table 105. Vistel Description and Major Businesses
Table 106. Vistel Product Features and Attributes
Table 107. Vistel Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. Vistel Recent Developments
Table 109. RETINA-AI Health Corporation Information
Table 110. RETINA-AI Health Description and Major Businesses
Table 111. RETINA-AI Health Product Features and Attributes
Table 112. RETINA-AI Health Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. RETINA-AI Health Recent Developments
Table 114. Acer Medical Corporation Information
Table 115. Acer Medical Description and Major Businesses
Table 116. Acer Medical Product Features and Attributes
Table 117. Acer Medical Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. Acer Medical Recent Developments
Table 119. Raw Materials Key Suppliers
Table 120. Distributors List
Table 121. Market Trends and Market Evolution
Table 122. Market Drivers and Opportunities
Table 123. Market Challenges, Risks, and Restraints
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Age-Related Macular Degeneration (AMD) AI Screening System Product Picture
Figure 2. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Hardware Product Picture
Figure 4. Software Product Picture
Figure 5. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Medical Institutions
Figure 7. Great Health Scene
Figure 8. Age-Related Macular Degeneration (AMD) AI Screening System Report Years Considered
Figure 9. Global Age-Related Macular Degeneration (AMD) AI Screening System Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 10. Global Age-Related Macular Degeneration (AMD) AI Screening System Revenue (2020-2031) & (US$ Million)
Figure 11. Global Age-Related Macular Degeneration (AMD) AI Screening System Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 12. Global Age-Related Macular Degeneration (AMD) AI Screening System Revenue Market Share by Region (2020-2031)
Figure 13. Global Age-Related Macular Degeneration (AMD) AI Screening System Revenue Market Share Ranking (2024)
Figure 14. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 15. Hardware Revenue Market Share by Player in 2024
Figure 16. Software Revenue Market Share by Player in 2024
Figure 17. Global Age-Related Macular Degeneration (AMD) AI Screening System Revenue Market Share by Type (2020-2031)
Figure 18. Global Age-Related Macular Degeneration (AMD) AI Screening System Revenue Market Share by Application (2020-2031)
Figure 19. North America Age-Related Macular Degeneration (AMD) AI Screening System Revenue YoY (2020-2031) & (US$ Million)
Figure 20. North America Top 5 Players Age-Related Macular Degeneration (AMD) AI Screening System Revenue (US$ Million) in 2024
Figure 21. North America Age-Related Macular Degeneration (AMD) AI Screening System Revenue (US$ Million) by Type (2020 - 2031)
Figure 22. North America Age-Related Macular Degeneration (AMD) AI Screening System Revenue (US$ Million) by Application (2020-2031)
Figure 23. US Age-Related Macular Degeneration (AMD) AI Screening System Revenue (2020-2031) & (US$ Million)
Figure 24. Canada Age-Related Macular Degeneration (AMD) AI Screening System Revenue (2020-2031) & (US$ Million)
Figure 25. Mexico Age-Related Macular Degeneration (AMD) AI Screening System Revenue (2020-2031) & (US$ Million)
Figure 26. Europe Age-Related Macular Degeneration (AMD) AI Screening System Revenue YoY (2020-2031) & (US$ Million)
Figure 27. Europe Top 5 Players Age-Related Macular Degeneration (AMD) AI Screening System Revenue (US$ Million) in 2024
Figure 28. Europe Age-Related Macular Degeneration (AMD) AI Screening System Revenue (US$ Million) by Type (2020-2031)
Figure 29. Europe Age-Related Macular Degeneration (AMD) AI Screening System Revenue (US$ Million) by Application (2020-2031)
Figure 30. Germany Age-Related Macular Degeneration (AMD) AI Screening System Revenue (2020-2031) & (US$ Million)
Figure 31. France Age-Related Macular Degeneration (AMD) AI Screening System Revenue (2020-2031) & (US$ Million)
Figure 32. U.K. Age-Related Macular Degeneration (AMD) AI Screening System Revenue (2020-2031) & (US$ Million)
Figure 33. Italy Age-Related Macular Degeneration (AMD) AI Screening System Revenue (2020-2031) & (US$ Million)
Figure 34. Russia Age-Related Macular Degeneration (AMD) AI Screening System Revenue (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Age-Related Macular Degeneration (AMD) AI Screening System Revenue YoY (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Top 8 Players Age-Related Macular Degeneration (AMD) AI Screening System Revenue (US$ Million) in 2024
Figure 37. Asia-Pacific Age-Related Macular Degeneration (AMD) AI Screening System Revenue (US$ Million) by Type (2020-2031)
Figure 38. Asia-Pacific Age-Related Macular Degeneration (AMD) AI Screening System Revenue (US$ Million) by Application (2020-2031)
Figure 39. Indonesia Age-Related Macular Degeneration (AMD) AI Screening System Revenue (2020-2031) & (US$ Million)
Figure 40. Japan Age-Related Macular Degeneration (AMD) AI Screening System Revenue (2020-2031) & (US$ Million)
Figure 41. South Korea Age-Related Macular Degeneration (AMD) AI Screening System Revenue (2020-2031) & (US$ Million)
Figure 42. Australia Age-Related Macular Degeneration (AMD) AI Screening System Revenue (2020-2031) & (US$ Million)
Figure 43. India Age-Related Macular Degeneration (AMD) AI Screening System Revenue (2020-2031) & (US$ Million)
Figure 44. Indonesia Age-Related Macular Degeneration (AMD) AI Screening System Revenue (2020-2031) & (US$ Million)
Figure 45. Vietnam Age-Related Macular Degeneration (AMD) AI Screening System Revenue (2020-2031) & (US$ Million)
Figure 46. Malaysia Age-Related Macular Degeneration (AMD) AI Screening System Revenue (2020-2031) & (US$ Million)
Figure 47. Philippines Age-Related Macular Degeneration (AMD) AI Screening System Revenue (2020-2031) & (US$ Million)
Figure 48. Singapore Age-Related Macular Degeneration (AMD) AI Screening System Revenue (2020-2031) & (US$ Million)
Figure 49. Central and South America Age-Related Macular Degeneration (AMD) AI Screening System Revenue YoY (2020-2031) & (US$ Million)
Figure 50. Central and South America Top 5 Players Age-Related Macular Degeneration (AMD) AI Screening System Revenue (US$ Million) in 2024
Figure 51. Central and South America Age-Related Macular Degeneration (AMD) AI Screening System Revenue (US$ Million) by Type (2020-2031)
Figure 52. Central and South America Age-Related Macular Degeneration (AMD) AI Screening System Revenue (US$ Million) by Application (2020-2031)
Figure 53. Brazil Age-Related Macular Degeneration (AMD) AI Screening System Revenue (2020-2025) & (US$ Million)
Figure 54. Argentina Age-Related Macular Degeneration (AMD) AI Screening System Revenue (2020-2025) & (US$ Million)
Figure 55. Middle East and Africa Age-Related Macular Degeneration (AMD) AI Screening System Revenue YoY (2020-2031) & (US$ Million)
Figure 56. Middle East and Africa Top 5 Players Age-Related Macular Degeneration (AMD) AI Screening System Revenue (US$ Million) in 2024
Figure 57. South America Age-Related Macular Degeneration (AMD) AI Screening System Revenue (US$ Million) by Type (2020-2031)
Figure 58. Middle East and Africa Age-Related Macular Degeneration (AMD) AI Screening System Revenue (US$ Million) by Application (2020-2031)
Figure 59. GCC Countries Age-Related Macular Degeneration (AMD) AI Screening System Revenue (2020-2025) & (US$ Million)
Figure 60. Israel Age-Related Macular Degeneration (AMD) AI Screening System Revenue (2020-2025) & (US$ Million)
Figure 61. Egypt Age-Related Macular Degeneration (AMD) AI Screening System Revenue (2020-2025) & (US$ Million)
Figure 62. South Africa Age-Related Macular Degeneration (AMD) AI Screening System Revenue (2020-2025) & (US$ Million)
Figure 63. Age-Related Macular Degeneration (AMD) AI Screening System Industry Chain Mapping
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed